{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:30:52Z","timestamp":1740184252741,"version":"3.37.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 16K09882"],"award-info":[{"award-number":["JP 16K09882"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jtct.2023.01.005","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T02:12:08Z","timestamp":1673489528000},"page":"273.e1-273.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor Types"],"prefix":"10.1016","volume":"29","author":[{"given":"Katsuji","family":"Kaida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5421-7470","authenticated-orcid":false,"given":"Kazuhiro","family":"Ikegame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2450-7573","authenticated-orcid":false,"given":"Satoshi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-3179","authenticated-orcid":false,"given":"Noriko","family":"Doki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Eto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Kawakita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0393-4066","authenticated-orcid":false,"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-2870","authenticated-orcid":false,"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8930-8762","authenticated-orcid":false,"given":"Takashi","family":"Daimon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.01.005_bib0001","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1200\/JCO.2010.28.8852","article-title":"Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure","volume":"28","author":"Duval","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.01.005_bib0002","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/sj.bmt.1702690","article-title":"Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle (SFGM)","volume":"26","author":"Michallet","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.005_bib0003","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.bmt.1705207","article-title":"Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up","volume":"37","author":"Oyekunle","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.005_bib0004","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2006.06.007","article-title":"Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning","volume":"12","author":"Ogawa","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.005_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2007.08.013","article-title":"Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis","volume":"36","author":"Ogawa","year":"2008","journal-title":"Exp Hematol"},{"issue":"3","key":"10.1016\/j.jtct.2023.01.005_bib0006","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/01.TP.0000128627.28212.D7","article-title":"Powerful graft-versus-leukemia effects exerted by HLA-haploidentical grafts engrafted with a reduced-intensity regimen for relapse following myeloablative HLA-matched transplantation","volume":"78","author":"Ogawa","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2023.01.005_bib0007","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4049\/jimmunol.1402950","article-title":"Host Foxp3+CD4+ regulatory T cells act as a negative regulator of dendritic cells in the peritransplantation period","volume":"196","author":"Inoue","year":"2016","journal-title":"J Immunol"},{"issue":"22","key":"10.1016\/j.jtct.2023.01.005_bib0008","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153551","article-title":"Peritransplant glucocorticoids redistribute donor T cells to the bone marrow and prevent relapse after haploidentical SCT","volume":"6","author":"Inoue","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtct.2023.01.005_bib0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","article-title":"Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)","volume":"103","author":"Atsuta","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2023.01.005_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12185-015-1907-9","article-title":"Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation","volume":"103","author":"Kanda","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2023.01.005_bib0011","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.bbmt.2015.04.012","article-title":"Unmanipulated haploidentical RIST using fludarabine, busulfan, low-dose ATG and steroid for patients in non-CR or at high risk of relapse: a prospective multicenter phase I\/II study in Japan","volume":"21","author":"Ikegame","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.005_bib0012","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bbmt.2014.01.003","article-title":"Changes in the clinical impact of high-risk human leukocyte antigen allele mismatch combinations on the outcome of unrelated bone marrow transplantation","volume":"20","author":"Kanda","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.005_bib0013","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12185-014-1542-x","article-title":"Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced-intensity conditioning","volume":"99","author":"Kaida","year":"2014","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2023.01.005_bib0014","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.005_bib0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.jtct.2023.01.005_bib0016","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41409-017-0028-x","article-title":"Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR","volume":"53","author":"Ogawa","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.005_bib0017","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.01.005_bib0018","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2023.01.005_bib0019","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/asheducation-2005.1.384","article-title":"Reduced-intensity conditioning regimens for hematologic malignancies: what have we learned over the last 10 years?","volume":"2005","author":"Giralt","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtct.2023.01.005_bib0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.005_bib0021","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.jtct.2023.01.005_bib0022","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jtct.2023.01.005_bib0023","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.005_bib0024","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbmt.2012.09.017","article-title":"Impact of the direction of HLA mismatch on transplantation outcomes in single unrelated cord blood transplantation","volume":"19","author":"Kanda","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.005_bib0025","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2011-03-344853","article-title":"Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts","volume":"118","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.01.005_bib0026","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1182\/blood.V80.4.1090.1090","article-title":"Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy","volume":"80","author":"Biggs","year":"1992","journal-title":"Blood"},{"issue":"8839","key":"10.1016\/j.jtct.2023.01.005_bib0027","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0140-6736(93)90067-Q","article-title":"Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation","volume":"341","author":"Schwarer","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2023.01.005_bib0028","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4049\/jimmunol.166.2.973","article-title":"Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question","volume":"166","author":"Suchin","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2023.01.005_bib0029","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1083-8791(99)70011-X","article-title":"Pathophysiology mechanism of acute graft-vs.-host disease","volume":"5","author":"Ferrara","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2023.01.005_bib0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbmt.2008.11.008","article-title":"Inflammation and bone marrow transplantation","volume":"15","author":"Hill","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.005_bib0031","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1182\/blood-2007-11-125294","article-title":"CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL","volume":"111","author":"Matte-Martone","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.01.005_bib0032","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","article-title":"Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation","volume":"107","author":"Lu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.01.005_bib0033","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1182\/blood-2011-02-339838","article-title":"Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome","volume":"118","author":"Lee","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.01.005_bib0034","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood-2015-04-639831","article-title":"Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia","volume":"126","author":"Ciurea","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.01.005_bib0035","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1200\/JCO.2015.63.8817","article-title":"Controlled, randomized, open-label trial of risk-stratified corticosteroid prevention of acute graft-versus-host disease after haploidentical transplantation","volume":"34","author":"Chang","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.01.005_bib0036","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbmt.2018.11.020","article-title":"Effects of low-dose glucocorticoid prophylaxis on chronic graft-versus-host disease and graft-versus-host disease-free, relapse-free survival after haploidentical transplantation: long-term follow-up of a controlled, randomized open-label trial","volume":"25","author":"Chang","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.005_bib0037","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/s41375-019-0686-3","article-title":"Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first complete remission: a prospective multicentre cohort study","volume":"34","author":"Yu","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.01.005_bib0038","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1506002","article-title":"Antilymphocyte globulin for prevention of chronic graft-versus-host disease","volume":"374","author":"Kr\u00f6ger","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T21:20:03Z","timestamp":1721683203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2666636723000295"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.01.005","relation":{},"ISSN":["2666-6367"],"issn-type":[{"type":"print","value":"2666-6367"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor Types","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}